Be part of the knowledge.™

The Clinical Testing for BRCA Mutations

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
In this segment, Dr. Critchfield examines diagnostic testing modalities for BRCA gene mutations that are available to physicians, their respective sensitivities and specificities, and clinical indications for choosing one test over another. He then discusses possible test results, the length of time required to receive them, and how such information is used by physicians and patients.

Gregory Critchfield, MD, MS

Gregory Critchfield, MD, MS

Michael Benson, MD

Michael Benson, MD

Recommended

Details

Presenters

Overview
In this segment, Dr. Critchfield examines diagnostic testing modalities for BRCA gene mutations that are available to physicians, their respective sensitivities and specificities, and clinical indications for choosing one test over another. He then discusses possible test results, the length of time required to receive them, and how such information is used by physicians and patients.

Gregory Critchfield, MD, MS

Gregory Critchfield, MD, MS

Michael Benson, MD

Michael Benson, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Evolving Our View of the Coagulation Cascade and Stroke Management

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis

M3: Managing the Cardiometabolic Risk in MASH

HF Management for Patients with Comorbid Conditions

Level Up Your Skills: Tailoring Management of HF

Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies

Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids